RNF11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.952400E-01
Normal-vs-Stage2
8.908000E-01
Normal-vs-Stage3
1.175780E-01
Normal-vs-Stage4
1.037840E-01
Stage1-vs-Stage2
8.542800E-01
Stage1-vs-Stage3
1.386850E-01
Stage1-vs-Stage4
1.239850E-01
Stage2-vs-Stage3
1.755960E-01
Stage2-vs-Stage4
8.732000E-02
Stage3-vs-Stage4
3.569200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.169400E-01
Normal-vs-AfricanAmerican
7.552400E-01
Normal-vs-Asian
6.112200E-01
Caucasian-vs-AfricanAmerican
4.609400E-01
Caucasian-vs-Asian
3.679600E-01
AfricanAmerican-vs-Asian
3.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.831000E-01
Normal-vs-Female
9.674800E-01
Male-vs-Female
4.605000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.541400E-01
Normal-vs-Age(41-60Yrs)
5.271800E-01
Normal-vs-Age(61-80Yrs)
7.438800E-01
Normal-vs-Age(81-100Yrs)
3.766600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.279600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.526600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.426800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.123620E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.381800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.090000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.116200E-01
Normal-vs-Daily Drinker
4.900200E-01
Normal-vs-Weekly Drinker
4.105400E-01
Normal-vs-Occasional Drinker
4.644000E-01
Normal-vs-Social Drinker
9.324000E-01
Non Drinker-vs-Daily Drinker
9.055200E-01
Non Drinker-vs-Weekly Drinker
8.155600E-01
Non Drinker-vs-Occasional Drinker
5.484500E-03
Non Drinker-vs-Social Drinker
2.191600E-01
Daily Drinker-vs-Weekly Drinker
9.051600E-01
Daily Drinker-vs-Occasional Drinker
8.417700E-03
Daily Drinker-vs-Social Drinker
2.294800E-01
Weekly Drinker-vs-Occasional Drinker
1.390410E-02
Weekly Drinker-vs-Social Drinker
2.505600E-01
Occasional Drinker-vs-Social Drinker
3.172200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.444400E-01
Normal-vs-Grade 2
4.862100E-02
Normal-vs-Grade 3
1.141400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.865400E-01
Grade 1-vs-Grade 3
5.936800E-01
Grade 1-vs-Grade 4
2.444400E-01
Grade 2-vs-Grade 3
4.739200E-01
Grade 2-vs-Grade 4
4.862100E-02
Grade 3-vs-Grade 4
1.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.360600E-01
Normal-vs-NonDiabetic
8.599000E-01
Diabetic-vs-NonDiabetic
5.981000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.519200E-01
Normal-vs-NoPancreatitis
9.065800E-01
Pancreatitis-vs-NoPancreatitis
3.827200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.641600E-01
Normal-vs-N1
9.160200E-01
N0-vs-N1
8.942400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.649200E-01
Normal-vs-TP53-NonMutant
9.157800E-01
TP53-Mutant-vs-TP53-NonMutant
8.160200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
